These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24614366)

  • 21. Evaluation of standard- and high-dose daptomycin versus linezolid against vancomycin-resistant Enterococcus isolates in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetations.
    Hall AD; Steed ME; Arias CA; Murray BE; Rybak MJ
    Antimicrob Agents Chemother; 2012 Jun; 56(6):3174-80. PubMed ID: 22470111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The clinical impact of linezolid susceptibility reporting in patients with vancomycin-resistant enterococci.
    Scheetz MH; Qi C; Noskin GA; Warren JR; Postelnick MJ; Malczynski M; Huang J; Zembower TR
    Diagn Microbiol Infect Dis; 2006 Dec; 56(4):407-13. PubMed ID: 16930924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Linezolid-resistant, vancomycin-resistant Enterococcus faecium infection in patients without prior exposure to linezolid.
    Rahim S; Pillai SK; Gold HS; Venkataraman L; Inglima K; Press RA
    Clin Infect Dis; 2003 Jun; 36(11):E146-8. PubMed ID: 12766857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Action of linezolid or vancomycin on biofilms in ventriculoperitoneal shunts in vitro.
    Bayston R; Ullas G; Ashraf W
    Antimicrob Agents Chemother; 2012 Jun; 56(6):2842-5. PubMed ID: 22430965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Central venous catheter colonization by linezolid-resistant, vancomycin-susceptible Enterococcus faecalis.
    Marra AR; Major Y; Edmond MB
    J Clin Microbiol; 2006 May; 44(5):1915-6. PubMed ID: 16672440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular detection of linezolid resistance in Enterococcus faecium and Enterococcus faecalis by use of 5' nuclease real-time PCR compared to a modified classical approach.
    Werner G; Strommenger B; Klare I; Witte W
    J Clin Microbiol; 2004 Nov; 42(11):5327-31. PubMed ID: 15528734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. First linezolid- and vancomycin-resistant Enterococcus faecium strain in Taiwan.
    Liao CH; Tseng SP; Fang CT; Teng LJ; Hsueh PR
    J Antimicrob Chemother; 2005 Apr; 55(4):598-9. PubMed ID: 15728149
    [No Abstract]   [Full Text] [Related]  

  • 28. Emerging linezolid-resistant, vancomycin resistant Enterococcus faecium from a patient of a haematological unit in Poland.
    Krawczyk B; Samet A; Bronk M; Hellmann A; Kur J
    Pol J Microbiol; 2004; 53(3):193-6. PubMed ID: 15702920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Species prevalence and antibacterial resistance of enterococci isolated in Kuwait hospitals.
    Udo EE; Al-Sweih N; Phillips OA; Chugh TD
    J Med Microbiol; 2003 Feb; 52(Pt 2):163-168. PubMed ID: 12543923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Linezolid-resistant enterococci in Greece: epidemiological characteristics.
    Spiliopoulou I; Damani A; Chini V; Zerva L; Kolonitsiou F; Anastassiou ED; Petinaki E
    Chemotherapy; 2011; 57(3):181-5. PubMed ID: 21474928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activities of Daptomycin, Linezolid, and Quinupristin-Dalfopristin against a challenge panel of Staphylococci and Enterococci, including vancomycin-intermediate staphylococcus aureus and vancomycin-resistant Enterococcus faecium.
    Jevitt LA; Smith AJ; Williams PP; Raney PM; McGowan JE; Tenover FC
    Microb Drug Resist; 2003; 9(4):389-93. PubMed ID: 15000746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful treatment of vancomycin-resistant enterococcus peritonitis using linezolid without catheter removal in a peritoneal dialysis patient.
    Song IJ; Seo JW; Kwon YE; Kim YL; Lim TS; Kang EW; Chang TI
    Perit Dial Int; 2014; 34(2):235-9. PubMed ID: 24676744
    [No Abstract]   [Full Text] [Related]  

  • 33. Nosocomial superinfections due to linezolid-resistant Enterococcus faecalis: evidence for a gene dosage effect on linezolid MICs.
    Ruggero KA; Schroeder LK; Schreckenberger PC; Mankin AS; Quinn JP
    Diagn Microbiol Infect Dis; 2003 Nov; 47(3):511-3. PubMed ID: 14596970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vancomycin-resistant Enterococcus spp.: validation of susceptibility testing and in vitro activity of vancomycin, linezolid, tigecycline and daptomycin.
    Rathe M; Kristensen L; Ellermann-Eriksen S; Thomsen MK; Schumacher H
    APMIS; 2010 Jan; 118(1):66-73. PubMed ID: 20041873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Linezolid resistance in Enterococcus faecium isolated in Ontario, Canada.
    Patel SN; Memari N; Shahinas D; Toye B; Jamieson FB; Farrell DJ
    Diagn Microbiol Infect Dis; 2013 Dec; 77(4):350-3. PubMed ID: 24095643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Response to emerging infection leading to outbreak of linezolid-resistant enterococci.
    Kainer MA; Devasia RA; Jones TF; Simmons BP; Melton K; Chow S; Broyles J; Moore KL; Craig AS; Schaffner W
    Emerg Infect Dis; 2007 Jul; 13(7):1024-30. PubMed ID: 18214174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimizing therapy for vancomycin-resistant enterococcal bacteremia in children.
    Tamma PD; Hsu AJ
    Curr Opin Infect Dis; 2014 Dec; 27(6):517-27. PubMed ID: 25313503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro activities of linezolid combined with other antimicrobial agents against Staphylococci, Enterococci, Pneumococci, and selected gram-negative organisms.
    Sweeney MT; Zurenko GE
    Antimicrob Agents Chemother; 2003 Jun; 47(6):1902-6. PubMed ID: 12760865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular Epidemiology of Vancomycin-Resistant Enterococcus faecalis and Enterococcus faecium Isolated from Clinical Specimens in the Northwest of Iran.
    Jahansepas A; Ahangarzadeh Rezaee M; Hasani A; Sharifi Y; Rahnamaye Farzami M; Dolatyar A; Aghazadeh M
    Microb Drug Resist; 2018 Oct; 24(8):1165-1173. PubMed ID: 29708837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Post-antibiotic growth suppression of linezolid against Gram-positive bacteria.
    Munckhof WJ; Giles C; Turnidge JD
    J Antimicrob Chemother; 2001 Jun; 47(6):879-83. PubMed ID: 11389123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.